Reduction in Disease Activity in Patients with RA and an Inadequate Response to MTX: Baricitinib Compared to Adalimumab and Placebo
ARTHRITIS & RHEUMATOLOGY（2018）
Key words
baricitinib,adalimumab,mtx,disease activity,placebo
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined